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Abstract
Brain-derived neurotrophic factor (BDNF) is a prototypic neurotrophin that regulates diverse
developmental events from the selection of neural progenitors to the terminal dendritic
differentiation and connectivity of neurons. We focus here on activity-dependent synaptic
regulation by BDNF and its receptor, full length TrkB. BDNF-TrkB signaling is involved in
transcription, translation, and trafficking of proteins during various phases of synaptic
development and has been implicated in several forms of synaptic plasticity. These functions are
carried out by a combination of the three signaling cascades triggered when BDNF binds TrkB:
the mitogen-activated protein kinase (MAPK), the phospholipase Cγ (PLC PLCγ), and the
phosphatidylinositol 3-kinase (PI3K) pathways. MAPK and PI3K play crucial roles in both
translation and/or trafficking of proteins induced by synaptic activity while PLCγ regulates
intracellular Ca2+ that can drive transcription via cyclic AMP and a Protein Kinase C. Conversely,
the abnormal regulation of BDNF is implicated in various developmental and neurodegenerative
diseases that perturb neural development and function. We will discuss the current state of
understanding BDNF signaling in the context of synaptic development and plasticity with a focus
on the post-synaptic cell and close with the evidence that basic mechanisms of BDNF function
still need to be understood in order to effectively treat genetic disruptions of these pathways that
cause devastating neurodevelopmental diseases.
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Introduction
Brain-derived neurotrophic factor (BDNF) was the second neurotrophin, after nerve growth
factor (NGF), to be isolated and sequenced. This feat was accomplished by Ives Barde and
his colleagues (Barde et al., 1982). They isolated 2 µg of BDNF from 3 kg of pig brains to
show that it supported the survival and fiber outgrowth of cultured embryonic chick sensory
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neurons and they cloned the molecule (Leibrock et al., 1989). With the sequence of both
NGF and BDNF available, conserved sequences were identified and many laboratories
began to probe DNA searching for other members of the neurotrophin family which now
totals 4–5 depending on the species referred to. In 1986 and '87, two laboratories reported on
the first neurotrophin receptor p75NTR which binds the neurotrophins with relatively low
affinity (Johnson et al., 1986; Radeke et al., 1987) and in 1991 the orphan receptors,
tropomyosin sensitive receptor kinases (Trks), were identified as the high affinity receptors
for the neurotrophin family of growth factors (Kaplan et al., 1991a; Kaplan et al., 1991b;
Klein et al., 1991a; Klein et al., 1991b; Soppet et al., 1991; Squinto et al., 1991). The Trks
frequently work together with p75NTR to register neurotrophin signaling at nanogram
levels. Since their discovery, Trk signaling, and in particular BDNF-TrkB signaling has been
implicated in a plethora of brain functions: neuronal cell survival, neurite growth, cell
migration, regulation of inhibitory-excitatory balance, and, more specifically, glutamate
dependent spine and dendritic growth, synapse formation, stabilization and potentiation.
This review discusses the synaptic effects of BDNF-TrkB signaling on, and within, post-
synaptic neurons during glutamatergic synaptic development. It closes with a hypothesis or,
more accurately a speculation, concerning how this particular locus of BDNF action may be
involved in mechanisms critical to neuron-wide stabilization of synapses as a first step in
establishing global brain circuitry in normal development and disease.
Regulation of BDNF / TrkB Signaling Pathway
The details of molecular properties of BDNF-TrkB signaling are beyond the scope of this
article and are reviewed elsewhere (Huang and Reichardt, 2003; Reichardt, 2006). Here, we
briefly summarize the findings. The Trk receptor tyrosine kinase family contains TrkA and
TrkC, receptors for NGF and neurotrophic factor 3 (NT3) respectively, as well as TrkB
which mediates the effect of BDNF and also neurotrophic factor 4/5 (NT 4/5).
There are several TrkB isoforms in the mammalian CNS. The full-length TrkB isoform
discussed here is a typical tyrosine kinase in that homodimerization during ligand binding
causes cross tyrosine phosphorylations in the intracellular Trk domains thereby initiating
transduction of the BDNF signal. These phosphorylation events then trigger MAPK, PI3K
or PLCγ intracellular cascades (Fig 1). Synaptic activity drives these signaling pathways that
regulate the assembling of TrkB with synaptic proteins (Fig. 2a), gene transcription (Fig.
2b), protein translation and trafficking (Fig. 2c). The three pathways can, at least
theoretically, work in parallel (Fig. 2d). Thus for most TrkB investigations, one Trk
signaling pathway is generally identified as necessary for an outcome, but seldom do these
experiments eliminate possible contributions, to the particular effect, of the other Trk
signaling pathways.
Phospholipase Cγ (PLCγ)
There are two tyrosine phosphorylation residues outside the kinase activation domain of
TrkB. Phospho-Tyr785 recruits and activates PLCγ which in turn hydrolyses
phosphatidylinositol 4,5-bisphosphate, to produce diacylglycerol (DAG) and inositol 1,4,5-
trisphosphate (IP3) (Huang and Reichardt, 2003; Reichardt, 2006). DAG activates protein
kinase C (PKC), and IP3 releases Ca2+ from intracellular stores. In developing hippocampal
neurons, focal application of BDNF results in fast calcium transients at postsynaptic sites
(Lang et al., 2007). The BDNF-induced release of intracellular Ca2+ together with DAG
activate the plasma membrane transient receptor potential canonical subfamily channel 3/6
(TRPC3/6) that contribute to BDNF-induced Ca2+ elevations at growth cones and synapses
(Li et al., 2005; Amaral and Pozzo-Miller, 2007).
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Some studies link the PLCγ pathways underlying BDNF induced Ca2+ transients directly to
synaptic plasticity. For example, in cultured cortical pyramidal neurons these transients
translocate GluR1 subunit of α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate receptors
(AMPAR), but not N-methyl-D-aspartic acid receptors (NMDAR) subunits to synapses. The
transients were due to release from intracellular stores requiring active IP3 receptors and a
contribution from TRPCs (Nakata and Nakamura, 2007). The Ca2+ elevation triggered by
PLCγ also increases Ca2+-sensitive adenyl cylclase (AC) activity that is necessary for the
formation of synaptic PSD-95-TrkB complexes (Ji et al., 2005) (Figure 2a) and that also is
involved in cyclic AMP responsive element binding (CREB)-dependent transcription
(Nguyen et al., 1994; Shaywitz and Greenberg, 1999) (Figure 2b).
Mitogen-Activated Protein Kinase (MAPK)
The other TrkB phosphorylation site on Tyr515 recruits Shc to TrkB and phosphorylates it.
In turn, Shc interacts with an adaptor protein Grb2 that recruits and activates the guanine
nucleotide exchange factor SOS. SOS promotes the removal of GDP from Ras that can then
bind GTP and become active. Ras activates the downstream kinase B-raf, MEK and MAPK/
Erk (Huang and Reichardt, 2003; Reichardt, 2006). MEK-MAPK/Erk signaling influences
transcription events, such as the activation of the CREB transcription factor (Shaywitz and
Greenberg, 1999) (Figure 2b). MAPK/Erk also regulates protein-synthesis dependent
plasticity by increasing phosphorylation of eukaryotic initiation factor 4E (eIF4E), the 4E-
binding protein 1 (4E-BP1) and ribosomal protein S6 (Kelleher et al., 2004; Klann and
Dever, 2004) (Figure 2c). Thus, MAPK/Erk plays a critical role in protein-synthesis
dependent plasticity.
Phosphatidylinositol 3-kinase (PI3K)
Recruitment of Shc to the Trk receptors also allows activation of the PI3K pathway by Ras,
via Grb2 (Reichardt, 2006). Activation of PI3K changes the composition of inositol
phospholipids in the inner leaflet of the plasma membrane. This results in the translocation
of Akt/protein kinase B to the plasma membrane. Activated Akt is involved in a variety of
functions such as cell survival, and protein translation. The TrkB-PI3K-AKT pathway
activates translation via a cascade driving the mammalian target of rapamycin (mTOR), a
major regulator of protein synthesis (Sarbassov et al., 2005). Akt accomplishes this by
downregulating the tuberous sclerosis complex (TSC) protein, TSC2 that forms a complex
with TSC1: a complex that otherwise inhibits Rheb a normal activator of mTOR. Active
mTOR phosphorylates p70S6 kinase and 4E-BP1 permitting mRNA translation. The PI3K-
Akt pathway also regulates the trafficking of synaptic proteins (Yoshii and Constantine-
Paton, 2007). Thus, this pathway plays pivotal roles in a long-term maintenance of synaptic
plasticity through translation and transport of synaptic proteins (Figure 2c).
BDNF-Dependent Structual Plasticity of Dendritic Spines
Spine Addition
There exists considerable evidence that BDNF-TrkB signaling can play a direct role in
excitatory synaptic morphogenesis. TrkB receptors have been found in postsynaptic
densities in rat cerebral cortex and hippocampus (Wu et al., 1996), and surface TrkB is
enriched at glutamatergic synapses colocalizing with NMDARs in cultured dissociated
cortical neurons (Gomes et al., 2006). In cerebellar cultures, BDNF increases the spine
density of Purkinje cells without affecting dendritic branching complexity (Shimada et al.,
1998). Chronic treatment of hippocampal slice cultures with BDNF increases synapse
number and spine density in apical dendrites of CA1 pyramidal neurons acting
predominately on short stubby spines without affecting dendritic length or branching.
However, when BDNF is applied along with botulinum toxin C to block even miniature
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synaptic release of neurotransmitter, the proportion of long thin, possibly immature, spines
is increased (Tyler and Pozzo-Miller, 2003). In the developing intact Xenopus tadpole,
BDNF also increases synapse density of tectal neurons (Sanchez et al., 2006).
In forebrain-specific transgenic mice expressing a dominant negative TrkB tagged with an
enhanced green fluorescent protein (EGFP), adult visual cortical neurons showed a
reduction in mushroom, (believed to be mature), spine maintenance and synaptic efficacy, as
well as an increase in long thin, spines and filopodia. However, in this same mouse, CA1
mushroom spine maintenance was unaffected suggesting that TrkB may play fundamentally
different roles in structural plasticity in different brain areas (Chakravarthy et al., 2006).
However, a recent study provides further evidence supporting a critical role of BDNF and
protein synthesis in hippocampal neuron spine growth (Tanaka et al., 2008). In rat
hippocampal slices, the repetitive pairing of postsynaptic spikes and two-photon uncaging of
glutamate at single spines (a spike timing plasticity protocol) produced both immediate and
gradual spine enlargement in CA1 pyramidal neurons. Protein synthesis inhibitors as well as
BDNF scavengers suppressed the gradual phase of enlargement.
There are also several mechanisms through which BDNF appears to facilitate spine
formation. An increase in spine density induced by BDNF in the hippocampus has been
shown to be dependent on TRPC3 channels which generate sustained cationic currents and
are activated by the TrkB-PLCγ pathway (Amaral and Pozzo-Miller, 2007). Also, through
another branch of the TrKB-PLCγpathway, enhancement of cyclic-AMP, a product of a
Ca2+-sensitive adenyl cylclase (AC) at synapses, or application of BDNF to cultured
neurons, increased synaptic colocalization of TrkB with the dominant glutamate receptor
scaffolding protein postsynaptic density protein-95 (PSD-95) and coimmunoprecipitation of
PSD-95 and TrkB increased in an activity-dependent manner (Ji et al., 2005; Yoshii and
Constantine-Paton, 2007) (Figure 2a). However, there is a second BDNF-dependent
mechanism that rapidly transports PSD-95 from the soma to the dendritic regions of
developing neurons in a PI3K-AKT- and microtubule- dependent, protein synthesis-
independent, process (Yoshii and Constantine-Paton, 2007). Thus two different TrkB-driven
pathways accomplish the trafficking of PSD-95 to dendrites and then to postsynaptic
densities: cAMP regulates formation of PSD-95-TrkB complex (Ji et al., 2005; Yoshii and
Constantine-Paton, 2007). PSD-95 binds many postsynaptic molecules that can regulate
activity-dependent spine growth. For example, PSD-95 binds Kalirin, a neuronal Rho-GEF
that facilitates actin polymerization and thereby contributes to spine growth (Penzes et al.,
2001). Simple overexpression of PSD-95 will increase spine number, size and synaptic
efficacy (El-Husseini et al., 2000), suggesting that TrkB signaling may play a central role in
facilitating glutamate synapse stabilization/maturation through the PSD-95 scaffold and
thereby exert its effects on glutamatergic synapse formation and function. MAPK / ERK1/2
activation is also necessary for BDNF to increase dendritic spine density in hippocampal
CA1 pyramidal neurons (Alonso et al., 2004). However, it is not clear if this response
requires transcription or translation.
In short, despite some regional differences in observations on TrkB-induced spine
development, it is likely that BDNF-TrkB signaling in the presence of synaptic activity can
facilitate spine morphogenesis particularly because similar changes in spine morphology
have been associated with long-term synaptic potentiation where, as will be discussed
below, considerable evidence for the requirement of TrkB signaling exists. Increase in
glutamatergic synapse activity stimulates the release of BDNF. BDNF, in turn, facilitates the
growth of immature spines into mature spines by controlling the assembly of TrkB-PSD-95
complex and protein synthesis (Figure 2).
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Spine Retraction
Spine retraction is another mechanism crucial to the regulation of dendritic spine density.
p75NTR can negatively modulate dendrite morphology and dendritic spine number of
hippocampal pyramidal neurons (Zagrebelsky et al., 2005). In wild-type animals,
overexpression of full-length p75NTR in pyramidal neurons resulted in a marked reduction
in dendritic length and complexity as well as spine density. Conversely, total spine density
increased by 100% and dendritic complexity was much greater in EGFP-labeled pyramidal
neurons in p75NTR−/− mice than in wild-type mice. As will be discussed further below, it
is an intriguing possibility that p75NTR signaling induces spine retraction by facilitating
long-term synaptic depression.
Physiological Synaptic Plasticity
Identifying any single mechanism for BDNF functional changes at synapses is difficult
because BDNF-TrkB signaling, either directly or indirectly work together with synaptic
activity to regulate synaptic strength of both excitatory and inhibitory connections. The latter
effect could be due to a BDNF effect on inhibitory hippocampal neurons of reducing the
reversal potential for GABAA currents thereby selectively decreasing the effect of inhibition
on GABA neurons and effectively increasing excitation in the neuropil (Wardle and Poo,
2003). The BDNF-TrkB induced changes in excitatory neurons results from increases in
internal Ca2+ (Balkowiec and Katz,2002;) and Ca2+ activation of adenyl cylase that can
activate transcription (Fig. 2) or the formation of PSD-95-TrkB complexes (Ji et al., 2005)
and NMDA-dependent BDNF activation can promote BDNF dependent synaptic delivery of
PSD-95 to dendrites and synapses through PI3K-Akt pathway as described above (Yoshii
and Constantine-Paton, 2007). BDNF also increases presynaptic, glutamate release. Thus in
the brief overview below we outline major findings without an attempt to identify the
progression of interacting events that produce functional synaptic change.
Changes in the strength of individual excitatory synapses are thought to enable
developmental refinement and information storage within neuronal circuits, and to represent
a cellular correlate of learning and memory. Long-term potentiation, also termed early LTP
(E-LTP), and NMDAR-dependent long-term depression (LTD) of synaptic efficacy, elicited
by a short period of synaptic stimulation, are partially mediated by local effects at the
stimulated synapse, including the incorporation or removal of AMPARs and the regulation
of dendritic spine turnover (Malinow and Malenka, 2002; Malenka and Bear, 2004;
Shepherd and Huganir, 2007). Increases in AMPAR at synapses occur in the early phase of
LTP (E-LTP) accompanied by rapid modification of synaptic proteins and the actin
cytoskeleton. E-LTP results in increases of synaptic strength that are of relatively short
duration (approximately 1 hour). A stronger synaptic stimulation induces late-LTP (L-LTP).
L-LTP lasts longer than a few hours (Huang and Kandel,1994) and requires the synthesis of
proteins that stably alter neuronal function (Nguyen et al, 1994). Accumulating evidence
suggests that BDNF affects both E- and LLTP through both pre- and post-synaptic
mechanisms and that both of these mechanisms are involved in learning and initiating
activity-dependent tuning of developing circuits (Poo, 2001; Lu et al., 2005).
Hippocampal LTP
Of all the neurotrophins, BDNF is by far the best characterized for its role in regulating
hippocampal LTP that occurs at the synapses from CA3 pyramidal neurons onto CA1
pyramidal neurons. LTP in the hippocampus is attenuated in a variety of experiments where
BDNF signaling is decreased in BDNF −/− or TrkB mutant mice, or by application of TrkB
ligand binding sites fused to the Fc region of immunoglobulin G (TrkB-Fc) that adsorb
endogeneous BDNF (Korte et al., 1995; Patterson et al., 1996; Chen et al., 1999; Xu et al.,
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2000; Minichiello et al., 2002). Impaired LTP in BDNF −/− mice can be recovered by
increasing BDNF either by direct application (Patterson et al., 1996; Pozzo-Miller et al.,
1999) or virus mediated transfer of the BDNF gene (Korte et al., 1996). In addition, a weak
synaptic activation, below the LTP threshold, induces LTP when BDNF is simultaneously
applied (Figurov et al., 1996; Kovalchuk et al., 2002). It is thought that the potentiating
effect of BDNF on E-LTP is achieved, at least in part, by enhancing synaptic responses to
high frequency stimulation and by presynaptically facilitating synaptic vesicle docking
(Pozzo-Miller et al., 1999; Jovanovic et al., 2000; Xu et al., 2000; Tyler and Pozzo-Miller,
2001). A brief dendritic BDNF application causes postsynaptic Ca2+ transients through
Ca2+ channels and NMDARs (Kovalchuk et al., 2002). In addition, Man et al. applied a
cocktail of NMDAR, antagonists of inhibitory receptors, and sodium channels, along with a
short burst of the NMDAR co-agonist glycine to produce AMPA incorporation into the
synapses of cultured hippocampal neurons (a chemical LTP) (Man et al., 2003). They found
that antagonism of PI3K blocked this effect. We also used the chemical LTP regime and
found that the activation of NMDAR triggers synaptic accumulation of PSD-95 (Yoshii and
Constantine-Paton, 2007) that can scaffold TARP-AMPAR complexes at the synapse
(Tomita et al., 2004). Anti-BDNF antibodies that scavenge BDNF blocked the effect of
chemical LTP indicating that glutamatergic activity is upstream of the BDNF-TrkB
signaling in this process (Yoshii and Constantine-Paton, 2007).
Ample studies indicate that BDNF is also involved in L-LTP. Acute application of BDNF to
hippocampal slices induces synaptic potentiation in the hippocampal CA1 region (Kang and
Schuman, 1995; Kang and Schuman, 1996; Kang et al., 1997). Also, in vivo infusion of
BDNF in the hippocampal dentate gyrus acutely induces an increase in field EPSP for 2 to10
hours indicative of L-LTP (Messaoudi et al., 1998). Treatment of hippocampal slices with
BDNF scavenging TrkB-Fc, or anti-BDNF can inhibit L-LTP (Kang et al., 1997). L-LTP is
impaired in TrkB knockout mice (Minichiello et al., 1999). Furthermore, an impairment of
L-LTP observed in BDNF−/− and +/− mice can be rescued by perfusion with exogenous
BDNF (Korte et al., 1996; Pang et al., 2004). Nevertheless many investigators have been
unable to reproduce LTP with BDNF alone. Thus the current evidence suggests that BDNF
facilitates activity of glutamatergic synapses and is crucial for the maintenance of L-LTP but
BDNF does not, by itself, induce L-LTP (Figurov et al., 1996; Patterson et al., 1996; Tanaka
et al., 1997; Frerking et al., 1998; Gottschalk et al., 1998; Huber et al., 1998). In addition,
BDNF is not involved in all forms of NMDAR-dependent LTP. Classic theta burst
stimulation which activates significant Ca2+ influx through L-type Ca2+ channels of CA1
pyramidal cells required BDNF for L-LTP but a similar BDNF treatment applied with 100
Hz stimulation did not induce L-LTP (Kang et al., 1997; Chen et al., 1999; Patterson et al.,
2001).
Assuming that BDNF is required for long-term maintenance of hippocampal LTP, one
premise is that it facilitates the synthesis of proteins that sustain a prolonged increase in
synaptic weight. Like BDNF-TrkB signaling, L-LTP is known to induce gene expression
through PI3K-Akt-mTOR and MAPK/Erk pathways in parallel (Klann and Dever, 2004).
Increases in cAMP induced by Forskolin can rapidly activate TrkB, (possibly by associating
it with PSD-95 and glutamate receptors) (Ji et al., 2005) and induce BDNF-dependent long-
lasting potentiation at the Schaffer collateral-CA1 synapse in hippocampus (Patterson et al.,
2001). TrkB activation by cAMP induces nuclear translocation of the activated MAPK to
the nucleus and CREB protein phosphorylation (Pizzorusso et al., 2000; Ying et al., 2002).
Studies exploring mTOR involvement in LLTP demonstrate that rapamycin, an mTOR
antagonist, blocks L-LTP and that proteins involved in mTOR-dependent protein elongation
are close to postsynaptic sites (Tang et al., 2002). This is a potential positive feedback
mechanisms that could produce L-LTP and a BDNF-induced synthesis of BDNF itself.
Supporting such a mechanism, BDNF mRNA levels increase in the hippocampal CA1
Yoshii and Constantine-Paton Page 6
Dev Neurobiol. Author manuscript; available in PMC 2011 April 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
region and dentate gyrus within 2–4 hours after the application of L-LTP-inducing
stimulation (Patterson et al., 1992; Castren et al., 1993; Dragunow et al., 1993) and BDNF
application to cultured neurons activates CREB which promotes transcription of BDNF
(Shaywitz and Greenberg, 1999).
Despite the large literature on PI3K and MAPK signaling pathways in BDNFdependent
plasticity, some dissenting evidence also exists. Both PI3K and the MAPK signaling
pathways require Shc as an adaptor protein, therefore Minichiello et al. (2002) compared
mice with targeted mutations in either the Shc- or the PLCγ-binding sites of TrkB
(Minichiello et al., 2002). Only the mutation of the PLCγ-binding sites blocked the early and
late phases of LTP in the CA1 region of the hippocampus whereas mutation of the Shc
docking site on TrkB was without effect on both early and late LTP. Also, simultaneous pre-
and post-synaptic expression of the PLC pleckstrin homology domain with viral vectors,
(these constructs block PLCγ signaling and IP3 production), suppressed the effect of TrkB
receptors on 80 minute LTP (Gartner et al., 2006). However, selective blockade of either
pre- or post-synaptic PLCγ signaling alone did not result in a significant reduction of LTP,
indicating that both sides of the synapse contribute to the effects of BDNF in LTP. This role
of TrkB coupling to PLCγ in LTP induced by high-frequency stimulation correlates with a
role of this signaling pathway in associative learning (Gruart et al., 2007). How this PLCγ
mechanism coordinates with PI3K and MAPK pathway signaling requires further study.
Proposed Model -Step I
Based on the experiments outlined above we postulate a biphasic scenario. First, similar to
E-LTP, NMDARs produce Ca2+ influx through both the NMDAR pore and L-type Ca2+
channels (Grover and Tyler, 1990) and BDNF-TrkB signaling also induces an increase in
internal Ca2+ increase through the PLCγ pathway. Pre-synaptically this PLCγ pathway
induces an increase in docked vesicles thereby releasing more glutamate. BDNF activation
due to NMDAR activity also increases delivery of PSD-95 to synapses (Yoshii and
Constantine-Paton, 2007). This initial phase sets the stage for the maintenance phase (L-
LTP) which depends on protein synthesis through PI3K pathway and may produce
additional synaptic proteins or mRNAs via MAPK and CREB activation. The outcome
(described below) is the formation of synaptic tags (Frey and Morris, 1997) that will allow
synapses throughout a neuron to be readily potentiated for a long period of time by even
mild synaptic activation.
LTD
While the contribution of BDNF-TrkB signaling to LTP has been well established, it is
unclear whether this pathway is involved in LTD. In visual cortical layer 2/3 neurons, an
application of BDNF prevents LTD which is otherwise induced by low frequency
stimulation of layer 4 neurons (Kinoshita et al., 1999). Conversely, recent studies indicate
that activation of p75NTR alone is important for NMDAR-dependent LTD in CA1
hippocampal neurons (Rosch et al., 2005; Woo et al., 2005). NMDAR-dependent LTD is
also absent in the hippocampal CA1 region of p75NTR-knockout mice without affecting
NMDAR-dependent LTP or NMDAR-independent LTD (Rosch et al., 2005; Woo et al.,
2005). Consistent with this functional data, other studies indicate that p75NTR−/− mice
have increased hippocampal neuron spine numbers (Koshimizu et al., 2009); that
overexpression of p75NTR in these neurons produces a decrease in spine number
(Zagrebelsky et al., 2005); and that application of a cleavage-resistant proBDNF reduces the
number of spines in cultured neurons (Koshimizu et al., 2009).
The p75NTR is known to bind pro-BDNF which can be cleaved by extracellular proteases
such as plasmin and induces neuronal apoptosis (Lee et al., 2001) and few dispute the
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observation that p75NTR can function without Trk receptors. However, the issue is whether
there is sufficient extracellular proBDNF neurotrophin in vivo to be the actual endogenous
ligand. The effect of synaptic attenuation by the recombinant proBDNF lead to endeavors by
two groups to determine how much pro-BDNF is secreted by neurons. Matsumoto et al.
used a mouse line in which the Bdnf gene was substituted with Bdnf-Myc and observed
secretion of Myc-tagged BDNF but not proBDNF, indicating efficient intracellular cleavage
to mature BDNF (Matsumoto et al., 2008). Over expression of BDNF in COS cells however
produced considerable more proBDNF in the extra-cellular medium. On the other hand,
Yang et al. (2009) used knock-in mice in which the Bdnf gene was tagged with a
hemagglutinin (HA) epitope (Yang et al., 2009). By immunoprecipitating the proteins from
the extra-cellular media and immunoblotting with antibodies against HA, they showed that
both BDNF and proBDNF were secreted by neurons but that proBDNF secretion is highest
in young neurons. Consequently, the nature of the p75NTR receptor ligand remains
contentious. Nevertheless, the correlation of extra-cellular proBDNF with highly expressed
BDNF is intriguing particularly since the exon structure of BDNF is complex with different
signaling pathways controlling each exon. As developmental neurobiologists it does not
seem impossible to us that there is developmental regulation of this exon usage allowing
high BDNF expression at some stages of development with consequently more secretion of
proBDNF and more p75NTR activation. For example see (Pruunsild et al., 2007; Tian et al.,
2009).
Visual Cortical Plasticity
The other region where BDNF involvement in synaptic plasticity has been studied
extensively is in the vertebrate visual pathway where many studies have focused on the
developmental plasticity that occurs during the critical period for ocular dominance
competition which is an important model for the mechanisms underlying development of
amblyopia in humans. The expression of BDNF increases during development and the onset
of pattern vision associated with eye-opening, or exposure to light after dark-rearing causes
a superimposed rapid increase in this neurotrophin (Castren et al., 1992). Also, because of
the extensive literature on its mature function as well as development, the visual system is
an excellent system to study BDNF/TrkB signaling among forebrain circuits. We
concentrate here only on the work dealing with mammalian visual cortex since the Cohen-
Corey article in this volume will be covering the exciting work on the amphibian retinal-
tectal pathway.
In many highly binocular mammals, cortical ocular dominance is accompanied by
segregation of the retinotopically organized thalamocortical axon terminals from left and
right retinas into eye-specific stripes within the afferent layers of visual cortex. These are
known as ocular dominance (OD) columns (Hubel et al., 1977). Visual deprivation is a
classical paradigm to study the plasticity of visual cortical connections. Prolonged or later
eyelid closure in young animals, known as monocular deprivation (MD), causes visual
cortical neurons to become dominated by the open eye. This is the phenomenon known as
OD plasticity and if the deprivation is prolonged through the "critical period", permanent
disruption of pattern vision develops in the deprived eye. Infusion of NT-4/5 or BDNF into
primary visual cortex of kittens blocks OD column formation around the infusion site
(Cabelli et al., 1995) but infusion of TrkB-Fc also inhibits the formation of OD patches
within layer 4 (Cabelli et al., 1997). These data suggest that the optimal level of BDNF is
necessary for the selective remodeling of visual thalamic axons into eyespecific zones and
that visual activity can regulate the BDNF-TrkB signaling in visual cortex. The latter notion
is supported by the findings that phosphorylated Trk (activated) receptors are reduced in
dark-reared, relative to light-reared animals (Viegi et al., 2002), and that BDNF is reduced
in visual cortex receiving most of its input from a MD eye (Rossi et al., 1999). However,
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infusion of BDNF into 4–5 week old kittens who were monocularly deprived caused an
enlargement of OD columns of the deprived eye contrary to a postulate that more active
synapses are more likely to take advantage of available BDNF than inactive ones (Galuske
et al., 2000). Furthermore, in contrast to the infusion experiments, BDNF overexpressing
transgenic mice showed the same degree of susceptibility to MD as wild type mice, but only
during a precocious critical period (Hanover et al., 1999; Huang et al., 1999).
In visual cortex, there is an age-dependent decline of cortical LTP that appears to be
mediated by the development of cortical inhibition. BDNF overexpression resulted in this
cortical inhibition occurring earlier. These overexpressing transgenic mice also showed a
precocious development of visual acuity and an earlier termination of the critical period for
MD induced OD plasticity, indicating that BDNF regulates many aspects of cortical
development probably through direct (or indirect effects) on cortical inhibition (Huang et al.,
1999). As discussed above, BDNF induces the formation of dendritic spines that are sites of
excitatory synapses. Therefore results indicating that over-expression of BDNF causes
earlier development of inhibitory circuitry in mouse visual cortex were somewhat surprising
(Hanover et al., 1999; Huang et al., 1999). However, the effect on inhibition could be
indirect, resulting from early increases in excitatory drive. This interpretation is consistent
with the observation that overexpressing mice also have a precocious onset of the critical
period (Hanover et al., 1999; Huang et al., 1999). The normal timing of critical period onset
has been shown to be dependent on light stimulation that increases excitatory activity in the
visual pathway.
A recent study on OD plasticity took advantage of knock-in mice with a mutation in the
ATP binding site that causes TrkB kinase activity to be eliminated by the compound 1NM-
PP1 (Chen et al., 2005). The acute blockade of TrkB kinase activity in MD mouse cortex by
osmotic mini-pump infusion of 1NM-PP1 did not interrupt the shift of OD plasticity.
However, in control animals, reopening of the deprived eye corrects the OD shift during the
critical period. However, 1NM-PP1 inhibition of TrkB blocked this recovery. These findings
suggest a trophic role for TrkB signaling in enhancement of newly active synapses or
growth of new connections from the previously deprived eye (Kaneko et al., 2008). They
could also reflect the absence of BDNF mediated PSD-95 increases in nascent synapses
from the previously deprived eye. The lack of BDNF-triggered increase in PSD-95 could
suppress any increase in the strength of the newly active synapses from a previously-
deprived eye and/or eliminate any competition between inputs from a previously-deprived
eye and from a non-deprived eye. Suppression of PSD-95 expression using siRNA has been
shown to decrease developmental increases of AMPARs in cultured hippocampal slices
(Ehrlich et al., 2007), to eliminate a rapid increase in PSD-95 upon controlled eye-opening
(Yoshii et al., 2003), and also the rapid appearance of LTP in the superior colliculus at this
time (Zhao et al., 2006; Zhao et al., 2007). These findings are tied to TrkB function because
in ongoing studies in intact visual cortex (Yoshii et al., 2008) we are finding that TrkB
inhibition with 1NM-PP1 suppresses an increase in PSD-95 at visual cortical synapses
similar to that previously described in cultured visual cortical cells (Yoshii and Constantine-
Paton, 2007).
Taken together, the work on BDNF in the hippocampus and visual pathway implicate BDNF
in the maturation of excitatory synapse by participating in L-LTP and, at least partly by
regulating trafficking of PSD-95 to glutamate synapses and also, either directly or indirectly,
by selectively increasing excitation and decreasing inhibition, accelerates (Wardle and Poo,
2003) the integration of inhibitory neurons into the CNS circuitry.
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Synaptic Tagging
NMDA receptor-dependent LTP and LTD are major synaptic mechanisms that either
strengthen or weaken a neuron's connectivity with neighboring neurons and with long axon
inputs from other regions of the brain using correlation or lack of correlation in the temporal
patterning of the target cell's inputs. At the cellular level, the neuronal output is based on the
integrated activity of individual synapses across the a neuron's dendritic tree. In learning and
memory as well as initial development of circuitry, this integration must be ongoing over
intervals longer than single synaptic responses. The latter requires some form of dendrite-
wide or target-cell-population-wide long-term cellular memory. One of the most carefully
documented examples of such a memory mechanism is "synaptic tagging" first described by
Frey and Morris in 1997 (Frey and Morris, 1997). The tagging process is outlined here
because it is likely to involve BDNF-Trk signaling at several stages.
Frey and Morris examined this integration mechanism using the hippocampal slice
preparation and stimulated CA3 inputs onto the apical dendritic trees of CA1 pyramidal
neurons (Frey and Morris, 1997). They activated one synaptic input with repetitive
tetanization to produce protein synthesis-dependent L-LTP. If a second input onto the same
apical dendritic tree was activated to produce E-LTP within 3 hours of the first induction,
this stimulation would evoke L-LTP at the second input without the requirement of protein
synthesis. They proposed that the initial L-LTP initiates the creation of short-lasting (less
than 3 hours) 'tags' and plasticity related proteins (PRP) at the heavily potentiated synapses
and these molecules diffuse through the dendrites. Other synapses on these dendrites
become labeled with the tag and weakly potentiated synapses that develop within 3 hrs can
use this tag to "capture" the PRPs. The capture of the PRPs by the weakly driven synapses as
a result of their "tag" then allows these E-LTP expressing synapses to develop L-LTP
independent of local proteins synthesis. A similar scenario occurs even between L-LTD and
E-LTD. Specifically, an initial activation of a protein-synthesis-dependent, late, long-term
depression in synaptic strength at one synapse allows a subsequent weaker stimulus on the
same dendritic tree to develop a protein-synthesis-dependent, late, long-term depression in
synaptic strength. Furthermore, a phenomenon of "cross-tagging" has also been described in
which proteins induced by prior L-LTD can be captured by "tagged" E-LTP” synapse and
transformed into L-LTP or vice versa (Sajikumar and Frey, 2004). This raises the intriguing
possibility that the same PRPs are synthesized in response to either L-LTP- or L-LTD
inducing stimuli and the type of stimulus delivered to a tagged synapse determines the
direction of the synaptic change that is consolidated. Protein kinase Mζ (PKMζ), an isoform
of PKC, is induced by L-LTP-inducing stimulation, and its activity is required for the
maintenance of L-LTP (Sajikumar et al., 2005). PI3K-Akt-mTOR and MAPK/Erk pathways
are required for L-LTP because of their role in local protein synthesis. However, an
additional function of TrkB in the synaptic tagging process could be to activate PKMζ via
PLCγ signaling.
The properties of the BDNF-TrkB signaling system that suggest its role in the synaptic
tagging process are: 1) The requirement of BDNF-TrkB activation for dendritic translation
of proteins that could be PRPs and the observation that exogenous BDNF is sufficient to
maintain L-LTP in the presence of protein synthesis inhibitors suggesting that BDNF itself
could be the most important PRP (Pang et al., 2004); 2) The fact that the BDNF-TrkB
pathway interacts with the scaffolding and trafficking systems of glutamatergic synapses.
For example, as mentioned previously, increases in neuronal activities after eye-opening,
and associated increases in cyclic AMP, TrkB-PSD-95 association and rapid addition of
PSD-95 at synapses (Ji et al., 2005; Yoshii and Constantine-Paton, 2007). Also PSD-95, the
major scaffold for NMDA and AMPA receptors at glutamatergic synapses, when knocked
down (KD) with siRNA in postsynaptic neurons, reduces the number of active synapses and
decreases LTP in the KD neurons even when the LTP stimulus response in the cells is
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increased to the same levels as control cells (Zhao et al., 2007). Furthermore, when PSD-95
is over-expressed in particular neurons, it facilitates synaptic strengthening as evident by the
fact that LTP is occluded (saturated) and LTD is increased (Beique and Andrade, 2003;
Stein et al., 2003; Ehrlich and Malinow, 2004); 3) In addition in VP16-CREB mice which
have an elevated BDNF level caused by constitutive activity of CREB, a weak tetanus can
induce L-LTP, that is reversed by TrkB-Fc application (Barco et al., 2005). Furthermore,
mice with the BDNF gene deleted only in CA1 neurons that would otherwise produce PRPs
in response to strong LTP stimulation seem to lack synaptic "tags": that is, a weak second
tetanus at a different synapse of the same cell can no produce L-LTP (Barco et al., 2005).
We became interested in the synaptic tagging hypothesis as a result of experiments showing
that eye-opening significantly increased PSD-95 in developing visual synapses within 2–3
hours (Yoshii et al., 2003). In pursing the mechanism of this increase we discovered that full
length TrkB co-immunopercipitated with PSD-95 but not with SAP 102, a glutamate
receptor scaffold which appears earlier than PSD-95 (Yoshii and Constantine-Paton, 2007).
Furthermore, the amount of TrkB associated with PSD-95 increased after eye-opening in
visual cortex.
To determine if TrkB signaling was involved in the synaptic increase of PSD-95 throughout
the dendrites of young visual cortical neurons in culture, we employed application of BDNF
or the NMDA stimulation regime known to produce chemical LTP through PI3K (Man et
al., 2003). These experiments used a fluorescent recovery after photobleaching (FRAP)
assay in dendritic segments of visual cortical neurons transfected with GFP-tagged PSD-95.
By measuring the rate and degree of PSD-95 FRAP we showed that BDNF as well as
chemical LTP applied to the visual cortical neuronal cultures increased the rate of trafficking
of GFP-tagged PSD-95 into these bleached dendritic segments and into synaptic puncta
within 1hour. This acceleration of trafficking was not protein synthesis dependent but it was
completely eliminated by antagonism of TrkB, PI3K and Akt regardless of whether the
increase in trafficking was induced by chemical LTP or BDNF application. In addition, the
BDNF signaling proved to be downstream of chemical LTP because addition of a BDNF-
blocking antibody to the cultures inhibited the dendritic increases in PSD-95 induced by
chemical LTP. To more closely mimic BDNF activity at a synapse, we placed single
microspheres coated with BDNF against a dendrite of PSD-95-GFP expressing neurons with
a bleached segment (Fig. 3). PSD-95 trafficking with this local BDNF stimulation was as
effective as BDNF application to the entire culture. BDNF- coated bead clusters close to but
not touching a dendrite had no effect on the FRAP of the cell as did contacting beads lacking
BDNF. Unexpectedly, however, we observed a BDNF-induced facilitation of PSD-95
trafficking in a bleached segment even when a bead touched an entirely separate dendrite of
the cell.
Furthermore, consistent with the pan-dendritic trafficking of PSD-95 as a result of local
stimulation, we found that BDNF stimulation decreased endogenous PSD-95 in the somatic
endoplasmic reticulum (ER) and increased the amount of PSD-95 in the somatic Golgi
complex. Thus PSD-95, or perhaps some molecule transported to the dendrites along with
PSD-95, or docked at synapses as a result of the synaptic presence of this multi-molecular
scaffold, could be the synaptic tag that enables other synapses on young neurons to obtain L-
LTP without new protein synthesis.
Proposed Model Step 2
Consequently, we propose the following sequence of events to get young neurons primed to
achieve L-LTP and stabilized synapses. 1) Strong glutamate activation at one or a small
number of synapses (Fig. 4a); 2) subsequent activation of BDNF-TrkB-PI3K signaling; 3)
facilitation of PSD-95 export to the Golgi (Fig. 4b); 4) tagging/priming of other synapses for
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facilitated L-LTP as a result of PSD-95 transport throughout the other dendrites of the same
neuron (Fig. 4c). In this variation of the tagging model, at least within an hour or so
following the induction of L-LTP, local protein synthesis of the "tag" (PSD-95) is not
initially required because PI3K-Akt signaling can move PSD-95 from ER to Golgi and then
to trans-Golgi vesicles for microtubular transport to dendrites. However for long-term
changes such as the developmental stabilization of connections, protein synthesis would
have to refill a local pool of the tag because, if PSD-95 is a tag, it is known to turn over
rapidly at the synapse (Colledge et al., 2003). In this context it is interesting that PSD-95
mRNA has been found at dendrites in older neurons (Zalfa et al., 2007) suggesting that, to
maintain PSD-95 at selected synapses into adulthood, local protein synthesis could provide a
mechanism to reinforce only synapses receiving very active inputs.
Taken together, BDNF secretion following a local increase in synaptic activity regulates
both pan-dendritic trafficking of synaptic proteins such as PSD-95 and local protein
synthesis. PSD-95 serves as a platform to hold glutamate receptors as well as newly
synthesized PRPs and facilitates coincidence detection by allowing a potent synaptic input
to increase the probability that a subsequent, potentially weaker, different synapses of the
same neuron.
Implications for Therapeutic Strategies to treat for Developmental
Disorders
In closing, with this admittedly speculative and focused scenario for synapse stabilization as
a result of activity and BDNF signaling, it is worthwhile reflecting on whether the
interaction between BDNF and glutamate activity at synapses is, in fact, relevant to human
health and development. The explosion of research on the bases of genetic disease suggests
very strongly that this is the case. Diseases associated with some perturbation of BDNF
signaling are diverse: epilepsy (He et al., 2004); mood disorders (Neves-Pereira et al., 2002;
Sklar et al., 2002; Schumacher et al., 2005; Strauss et al., 2005), neurodegenerative diseases
such Huntington's Disease (Zuccato et al., 2001; Zuccato et al., 2003; Lynch et al., 2007),
Alzheimers Disease (Nagahara et al., 2009); and neurodevelopmental diseases including
Autism Spectrum Disorders (ASD). Rett Syndrome and Tuberous sclerosis represent two of
the best examples of diseases involving disrupted BDNF signaling and often presenting with
ASD. We use them as examples of how BDNF pathways can be involved in producing
complex and devastating childhood onset diseases.
Rett syndrome is an X-linked dominant disease, affecting girls almost exclusively because
males die as fetuses (Moretti and Zoghbi, 2006). Symptoms of Rett syndrome start between
6–18 months and include microcephaly, hand stereotypies, loss of purposeful hand use,
regression of language and motor milestones, autistic-like behavior and breathing
irregularities. Rett syndrome is usually caused by a mutation in the gene encoding methyl
CpG binding protein 2 (MeCP2) which is involved in chromatin remodeling and control of
gene transcription (Amir et al., 1999). MeCP2 mutant mice show impaired LTP, reduced
size of the PSD, deficits of memory and spatial learning (Moretti et al., 2006) and smaller,
less complex pyramidal neurons in cortical layers II and III, (Kishi and Macklis, 2004). In
cultured neurons, MeCP2 binds the promoter region of a Bdnf gene and suppresses its
transcription (Chen et al., 2003; Martinowich et al., 2003). However, BDNF protein levels
are decreased, not increased in brains of MeCP2 knockout mice (Chang et al., 2006). Recent
studies show that the Bdnf gene can be regulated by MeCP2 and that MeCP2 associates with
CREB1 at the promoter of an activated target, but not at the promoter of a repressed target
(Chahrour et al., 2008). Overexpression of BDNF restores locomotor activity levels in
MeCP2 mutant mice and relieves some symptoms of the mutant phenotype (Chang et al.,
2006). Another rescue study used insulin-like growth factor (IGF-1) that permeates the
Yoshii and Constantine-Paton Page 12
Dev Neurobiol. Author manuscript; available in PMC 2011 April 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
blood–brain barrier more effectively, yet shares overlapping neurotrophic effects with
BDNF. Systemic injection of IGF-1 partially restores spine density and synaptic amplitude,
increases PSD-95, and stabilizes cortical plasticity to wild-type levels in MeCP2 mutant
mice (Tropea et al., 2009). Nevertheless, little is known about whether cell type differences
or age dependent changes in BDNF pathway responses to these treatments exist or, in the
latter experiment, whether the overlapping effects that IGF shares with BDNF are
responsible for the changes observed.
The Tuberous sclerosis complex (TSC) is another childhood onset genetic disease that
involves multiple organs including brain, skin, lung, kidney, and heart (Crino et al., 2006).
The neurological symptoms include epilepsy, developmental delays, autistic behavior and
giant cell astrocytomas. TSC1 and TSC2 are the two causative genes. TSC-1 and −2 proteins
form a complex that negatively regulates the PI3K-AKT-mTOR cascade initiated by BDNF
and other growth factors (Crino et al., 2006). Loss of TSC1 or TSC2 results in enlargement
of somas and dysmorphic dendritic spines and also increases spontaneous miniature
AMPAR current (Tavazoie et al., 2005). Furthermore, synapsinpromoter driven conditional
Tsc1 knock-out mice show spontaneous seizures along with dysplastic and ectopic neurons
(Meikle et al., 2007). In cultured hippocampal neurons, the dendritic arbor growth
stimulated by either BDNF or overexpression of constitutively active mutants of Ras, PI3K
and Akt can be blocked by inhibition of mTOR (Kumar et al., 2005). Also mTOR inhibitors
including rapamycin can correct somal and dendritic hypertrophies, and improve survival,
seizure frequency and behavioral abnormalities in Tsc mutant mice (Ehninger et al., 2008;
Meikle et al., 2008). These results are consistent with the up-regulation of mTOR pathway
in TSC.
Collectively, Rett syndrome and TSC show that both up- and down-regulation of
neurotrophin-triggered signaling result in abnormal morphological and behavioral
phenotypes, indicating a requirement for the optimal level of BDNF-TrkB signaling in
normal development. While the pilot studies using mouse models indicate that therapeutic
intervention of neutorophin pathways is feasible in ameliorating some of the symptoms of
these neurodevelopmental disorders, it is not yet clear how these effects can be transferred to
afflicted patients. This is largely because, we still have a long way to fully understand how
neurotrophic signaling in general, and BDNF signaling in the brain in particular, is
differentially regulated. We also have little data on how the various pathways through which
BDNF pathways can signal, interact with the necessary processes of selective synapse
formation and maintenance, pruning of exuberant circuitry, and fine control of both protein
synthesis in general and local protein synthesis at synapses. Much more mechanistic
knowledge of the complexities of these pathways will be necessary before any interventions
developed in engineered mice can be brought to the bedside.
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Figure 1.
Binding of BDNF activates PLCγ, PI3K and MAPK pathways.
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Figure 2. BDNF-TrkB signaling Regulates Multiple Events through PLCγ, PI3K and MAPK
pathways
(a) PI3K pathway regulates trafficking and PSD-95 to a synapse and cAMP regulates
formation of synaptic PSD-95-TrkB complex.
(b) BDNF-TrkB signaling activates MAPK/Erk, increasese cAMP and activate CREB-
regulated gene transcription.
(c) BDNF-TrkB signaling regulates protein translation through both MAPK/Erk and PI3K-
Akt-mTOR pathways. PI3K-Akt also regulates protein trafficking in ER and Golgi.
(d) A diagram showing BDNF-TrkB signaling regulates multiple molecular events through
three pathways in parallel.
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Figure 3. BDNF bead application to a short dendritic segment facilitates PSD-95-GFP FRAP
throughout the dendritic tree of locally-stimulated neurons
(a) (Top row) BDNF covalently linked to a bead (pseudo-colored red) was placed in contact
with one dendritic branch and a dendritic segment nearby (white square) was bleached.
(Middle row) A segment of a completely separate dendrite was bleached after a BDNF-
coated bead was applied. (Bottom row) A group of BDNF-coated beads was placed near a
dendrite without contact. Scale, 10 µm.
(b) Magnified images of dendrites inside the white squares in Fig. 6(a). The branches from a
neuron contacting the BDNF-coated bead or a separate dendritic branch from a neuron with
a BNDF-coated bead contacting another one of its dendrites, show a more pronounced
FRAP of PSD-95-GFP than a branch from the neuron with near-by beads that have no
dendritic contact. Each image corresponds to a 21 µm × 21 µm bleached frame. Filled
arrowheads in the second row identify weak puncta and their recovery in a dendrite that was
expressing relatively low intensity PSD-95 puncta.
(c) FRAP graph summarizing the results of the dendrite-wide BDNF-bead-mediated
PSD-95-GFP FRAP. Application of BDNF-coated beads to one dendrite of transfected
neurons showed significantly facilitated PSD-95-GFP FRAP on distant dendrites of the
same cells. Beads coated only with BSA and touching a dendrite had no effect above
baseline on PSD-95-GFP FRAP in the dendrites of the contacted cell. Dendrites of nearby
cells that were not contacted by beads covalently coated with BDNF showed the same
baseline FRAP response seen with the BSA-coated beads. This lack of effect indicates that
the PSD-95-GFP FRAP shown by dendrites distant from the one contacted by the BDNF
bead were not driven by trace amounts of BDNF escaping from the bead. FRAP with bead
treatments are shown against shaded areas reflecting the difference between baseline FRAP
and FRAP with BDNF in the perfusion fluid. P=0.02 Error bar, s.e.m. (Adopted from Yoshii
and Constantine-Paton, 2007)
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Figure 4. A model for rapid, dendrite-wide, sensitization for synaptic potentiation conveyed by
local NMDAR and BDNF activity-driven-PSD-95 trafficking to synapses throughout the neuron
(a) Strong local NMDAR stimulation recruits TrkB to synapses, inserts AMPARs into
extrasynaptic membrane, and initiates BDNF signaling.
(b) Mature BDNF near the synapse stimulates TrkB. TrkB activates PI3K and Akt resulting
in facilitated PSD-95 localization to the Golgi and microtubule based transport along
dendrites.
(c) An increased probability (sensitization) of LTP occurs at synapses throughout the
dendritic tree as a result of dendrite-wide trafficking of PSD-95 from the Golgi. Synapses
with a surplus of PSD-95 can readily bind AMPAR-stargazin complexes at the synapse and
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consequently strengthen that contact if a young synapse activates NMDARs sufficiently to
drive AMPAR-stargazin complexes to the extrasynaptic membrane. (Adopted from Yoshii
and Constantine-Paton, 2007)
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